[go: up one dir, main page]

MX2010003843A - Composicion orodispersable que comprende acidos grasos poliinsaturados sin mal olor ni sabor. - Google Patents

Composicion orodispersable que comprende acidos grasos poliinsaturados sin mal olor ni sabor.

Info

Publication number
MX2010003843A
MX2010003843A MX2010003843A MX2010003843A MX2010003843A MX 2010003843 A MX2010003843 A MX 2010003843A MX 2010003843 A MX2010003843 A MX 2010003843A MX 2010003843 A MX2010003843 A MX 2010003843A MX 2010003843 A MX2010003843 A MX 2010003843A
Authority
MX
Mexico
Prior art keywords
taste
fatty acids
polyunsaturated fatty
bad odour
orodispersible composition
Prior art date
Application number
MX2010003843A
Other languages
English (en)
Inventor
Catherine Kabaradjian
Original Assignee
Bayer Consumer Care Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Consumer Care Ag filed Critical Bayer Consumer Care Ag
Publication of MX2010003843A publication Critical patent/MX2010003843A/es

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • A61K31/20Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A61K31/202Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having three or more double bonds, e.g. linolenic
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L27/00Spices; Flavouring agents or condiments; Artificial sweetening agents; Table salts; Dietetic salt substitutes; Preparation or treatment thereof
    • A23L27/84Flavour masking or reducing agents
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/115Fatty acids or derivatives thereof; Fats or oils
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/115Fatty acids or derivatives thereof; Fats or oils
    • A23L33/12Fatty acids or derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/06Antihyperlipidemics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Nutrition Science (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Mycology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Epidemiology (AREA)
  • Obesity (AREA)
  • Cardiology (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Immunology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Medicinal Preparation (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

La invención se refiere a una composición orodispersable sin mal olor ni sabor que comprende ácidos grasos poliinsaturados (PUFA en inglés), a su procedimiento de preparación y a su uso como suplemento nutricional o como suplemento dietético para equilibrar el nivel lipídico sanguíneo, evitando o reduciendo el riesgo de desarrollo de cambios, trastornos o enfermedades ateroscleróticos.
MX2010003843A 2007-10-30 2008-10-21 Composicion orodispersable que comprende acidos grasos poliinsaturados sin mal olor ni sabor. MX2010003843A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP07291305 2007-10-30
PCT/EP2008/008883 WO2009056248A1 (en) 2007-10-30 2008-10-21 Orodispersible composition comprising polyunsaturated fatty acids without bad odour or taste

Publications (1)

Publication Number Publication Date
MX2010003843A true MX2010003843A (es) 2010-07-30

Family

ID=40279125

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2010003843A MX2010003843A (es) 2007-10-30 2008-10-21 Composicion orodispersable que comprende acidos grasos poliinsaturados sin mal olor ni sabor.

Country Status (15)

Country Link
US (1) US20150038583A9 (es)
EP (1) EP2214628B1 (es)
AR (1) AR069129A1 (es)
AT (1) ATE529095T1 (es)
AU (1) AU2008317921B2 (es)
BR (1) BRPI0818797A2 (es)
CA (1) CA2703818C (es)
ES (1) ES2373624T3 (es)
MX (1) MX2010003843A (es)
PE (1) PE20090878A1 (es)
PL (1) PL2214628T3 (es)
RU (1) RU2493842C2 (es)
TW (1) TW200936164A (es)
UY (1) UY31411A1 (es)
WO (1) WO2009056248A1 (es)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9770047B2 (en) 2008-04-10 2017-09-26 U.S. Nutraceuticals, LLC Perilla seed composition
US8586104B2 (en) 2008-04-10 2013-11-19 U.S. Nutraceuticals, LLC Plant derived seed extract rich in essentially fatty acids derived from Salvia hispanica L. seed: composition of matter, manufacturing process and use
US9610313B2 (en) 2008-04-10 2017-04-04 U.S. Nutraceuticals Eye health composition and method using plant derived seed extract rich in essential fatty acids derived from perilla seed and carotenoids
US8784904B2 (en) 2008-04-10 2014-07-22 U.S. Nutraceuticals, LLC Plant derived seed extract rich in essential fatty acids derived from perilla seed: composition of matter, manufacturing process and use
CA2990230A1 (en) 2015-06-19 2016-12-22 University Of Southern California Compositions and methods for modified nutrient delivery
US10744070B2 (en) 2015-06-19 2020-08-18 University Of Southern California Enteral fast access tract platform system
CN110237261A (zh) * 2019-07-30 2019-09-17 珠海市东辰制药有限公司 一种复合崩解剂及其制备方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3702031A1 (de) * 1987-01-24 1988-08-04 Basf Ag Verfahren zur herstellung von mikrodispersen fischoelpraeparaten
JPH08259943A (ja) * 1995-03-21 1996-10-08 Nippon Suisan Kaisha Ltd 乳化油脂用酸化安定剤
US6630192B2 (en) * 1995-04-07 2003-10-07 Brandeis University Increasing the HDL level and the HDL/LDL ratio in human serum by balancing saturated and polyunsaturated dietary fatty acids
JP3841804B2 (ja) * 2003-10-15 2006-11-08 富士化学工業株式会社 口腔内速崩壊性錠剤用の組成物
UA88943C2 (ru) * 2005-02-03 2009-12-10 Нікомед Фарма Ас Быстрый способ влажного гранулирования для получения композиций, которые содержат кальций

Also Published As

Publication number Publication date
AR069129A1 (es) 2009-12-30
RU2010121715A (ru) 2011-12-10
UY31411A1 (es) 2009-05-29
BRPI0818797A2 (pt) 2014-10-07
EP2214628A1 (en) 2010-08-11
US20150038583A9 (en) 2015-02-05
EP2214628B1 (en) 2011-10-19
US20100216885A1 (en) 2010-08-26
ES2373624T3 (es) 2012-02-07
TW200936164A (en) 2009-09-01
WO2009056248A1 (en) 2009-05-07
AU2008317921B2 (en) 2014-04-03
PL2214628T3 (pl) 2012-03-30
RU2493842C2 (ru) 2013-09-27
CA2703818C (en) 2016-01-05
CA2703818A1 (en) 2009-05-07
PE20090878A1 (es) 2009-07-03
AU2008317921A1 (en) 2009-05-07
ATE529095T1 (de) 2011-11-15

Similar Documents

Publication Publication Date Title
MX2010003703A (es) Composicion que comprende acidos grasos poliinsaturados y carbon activado.
MX2010003843A (es) Composicion orodispersable que comprende acidos grasos poliinsaturados sin mal olor ni sabor.
BRPI0517776C8 (pt) composição de óleo de soja desodorizado, alvejado e refinado compreendendo ácido graxo poliinsaturado, bem como alimento, bebida, suplemento nutricional e óleo de cozinha compreendendo a referida composição
EA201071206A1 (ru) Композиции, содержащие липид, и способы их применения
MX2010002404A (es) Composiciones de grasa solida que contiene un acido graso poliinsaturado y usos y produccion de las mismas.
GB2459809A (en) Fatty acid formulations and methods of use thereof
MX2010005948A (es) Productos carnicos con niveles incrementados de acidos grasos beneficiosos.
MY162133A (en) Nutritional supplement containing long-chain polyunsaturated fatty acids
WO2009013596A3 (en) Fortification of nutritional products with olive extracts containing hydroxytyrosol and hydroxytyrosol fortified nutritional products
MX342733B (es) Composicion nutricional para promover el desarrollo y crecimiento sano.
MX2011012375A (es) Extracto de semillas enteras de moriga sp y uso del mismo en composiciones cosmeticas y/o dermatologicas.
WO2010129565A3 (en) Compositions, methods, and kits for polyunsaturated fatty acids from microalgae
EA201070419A1 (ru) Состав для регулирования метаболизма липидов
ZA200902673B (en) Ketogenic diet
WO2007092509A3 (en) Dietary supplement composition for blood lipid health
WO2007100766A3 (en) Health bars and compositions for improving cardiovascular risk factors
WO2010136900A3 (en) Methods of using krill oil to treat risk factors for metabolic disorders and obesity
BR112012007166A2 (pt) "composição de gordura alimentícia, método de uso de ácido estearidônico para formar uma composição de gordura alimentícia,composições alimentícias, manteiga de nozes e metodo para usar ácido esteardônico para formar uma manteiga de nozes.
MX2009004339A (es) Alcoholes de acido graso.
MXPA04001129A (es) Mezclas de lipidos y productos de alimento que contienen acido graso oleico y acidos grasos omega-6, disenadas para incrementar el nivel intramiocelular de lipidos.
DK1876906T3 (da) Kosttilskud eller functional food, indeholdende oliekombination
WO2008102017A3 (en) Food comprising polyunsaturated fatty acids for the prevention of chronic diseases
MX2012006790A (es) Composiciones de carne enriquecidas con acido graso omega-3.
MY159390A (en) Nutritional composition for infants
PH12016501111A1 (en) Composition comprising ferric saccharate and high concentrations of microencapsulated lc-pufa with a reduced off taste

Legal Events

Date Code Title Description
FG Grant or registration